University of Colorado Denver, School of Medicine, Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, MS 8106, PO box 6511, Aurora, CO 80045, USA.
Best Pract Res Clin Endocrinol Metab. 2009 Dec;23(6):793-800. doi: 10.1016/j.beem.2009.08.003.
Many different drugs affect thyroid function. Most of these drugs act at the level of the thyroid in patients with normal thyroid function, or at the level of thyroid hormone absorption or metabolism in patients requiring exogenous levothyroxine. A small subset of medications including glucocorticoids, dopamine agonists, somatostatin analogues and rexinoids affect thyroid function through suppression of TSH in the thyrotrope or hypothalamus. Fortunately, most of these medications do not cause clinically evident central hypothyroidism. A newer class of nuclear hormone receptors agonists, called rexinoids, cause clinically significant central hypothyroidism in most patients and dopamine agonists may exacerbate 'hypothyroidism' in patients with non-thyroidal illness. In this review, we explore mechanisms governing TSH suppression of these drugs and the clinical relevance of these effects.
许多不同的药物会影响甲状腺功能。这些药物中的大多数在甲状腺功能正常的患者中作用于甲状腺水平,或在外源性左甲状腺素需要的患者中作用于甲状腺激素吸收或代谢水平。一小部分药物,包括糖皮质激素、多巴胺激动剂、生长抑素类似物和视黄醇类,通过抑制促甲状腺激素在垂体或下丘脑中的分泌来影响甲状腺功能。幸运的是,这些药物中的大多数不会导致临床明显的中枢性甲状腺功能减退症。一类新的核激素受体激动剂,称为视黄醇类,会导致大多数患者出现临床显著的中枢性甲状腺功能减退症,而多巴胺激动剂可能会使非甲状腺疾病患者的“甲状腺功能减退症”恶化。在这篇综述中,我们探讨了这些药物抑制促甲状腺激素的机制及其对这些影响的临床相关性。